Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,652 GBX | +0.06% | +3.95% | +13.97% |
10:51am | GSK: FDA priority review for endometrial cancer | CF |
10:14am | GSK's Jemperli with chemotherapy accepted for priority review by FDA | AN |
Filters
- Stock Market
- Equities
- GSK Stock
- News GSK plc